While serving as Senior vice president and chief compliance officer of Amgen Inc., Anna Richo was responsible for the global pharmaceutical company’s compliance and business ethics programs. Anna Richo reported on environmental sustainability efforts for Amgen. An international biotechnology leader, Amgen continues to remain focused on using resources wisely and operating in an environmentally responsible manner. Amgen is committed to improved efficiency in research, in development of medicines, and in processes of manufacturing. Known for its innovative building policies, Amgen plans, constructs, and operates its facilities with a conservation mindset. Amgen sites around the world are evidence of this environmentally responsible construction. In Singapore, a state-of-the-art biomanufacturing plant has been built that will drastically reduce water use, solid waste output, and carbon emissions. Amgen’s considerable water conservation efforts in California and Puerto Rico have been stepped up even more in response to drought. Over the past several years, Amgen has increased energy conservation practices, which has largely reduced carbon emissions in the company. Amgen also lists renewable and alternative energy as a part of its long-term plans. This biology-focused company has a deep appreciation for natural resources and is continually looking for new ways to limit its impact on the environment.
0 Comments
Leave a Reply. |
AuthorAs of November 1, 2012, Anna Richo became Executive Vice President and General Counsel of UCB, a biopharmaceutical company headquartered in Brussels, Belgium. Archives
August 2018
Categories
All
|